−0.84USD
−31.39 MUSD
29.94 M
About Quince Therapeutics, Inc.
Sector
Industry
CEO
Dirk Thye
Website
Headquarters
South San Francisco
Employees (FY)
32
Founded
2012
ISIN
US22053A1079
FIGI
BBG00BTK1DT8
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QNCX is 1.05 USD — it has decreased by 0.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Quince Therapeutics, Inc. stocks are traded under the ticker QNCX.
Quince Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
QNCX stock is 4.96% volatile and has beta coefficient of 0.86. Check out the list of the most volatile stocks — is Quince Therapeutics, Inc. there?
QNCX earnings for the last quarter are −0.72 USD per share, whereas the estimation was −0.55 USD resulting in a −31.47% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about Quince Therapeutics, Inc. earnings.
Yes, you can track Quince Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
QNCX stock has risen by 8.25% compared to the previous week, the month change is a 11.76% fall, over the last year Quince Therapeutics, Inc. has showed a 28.08% decrease.
QNCX net income for the last quarter is −8.89 M USD, while the quarter before that showed −5.35 M USD of net income which accounts for −66.21% change. Track more Quince Therapeutics, Inc. financial stats to get the full picture.
Today Quince Therapeutics, Inc. has the market capitalization of 45.81 M, it has decreased by 0.95% over the last week.
No, QNCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QNCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quince Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 32.00 employees. See our rating of the largest employees — is Quince Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Quince Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Quince Therapeutics, Inc. stock shows the sell signal. See more of Quince Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.